Glenmark Pharma launches drug for diabetic patients with comorbidities
"Diabetes is growing in India at an alarming rate, and eight out of every ten diabetic patients suffer from comorbidities," Glenmark Pharmaceuticals EVP & Business Head India Formulations Alok Malik said.
About eight out of ten patients with diabetes also have one or more comorbidity in India, the drug firm stated. Pic: Reuters